biotech news today obesity drugs glp-1 Weight loss without side effects? Top researchers propose new approach Lilly is now pharma's top
Description
Hormones and diet, but not body weight, control hypothalamic microglial activity
doi: 10.1172/jci103327
Data from observational studies and subgroup analyses of RCTs show that GLP-1 RAs reduce HF outcomes and mortality in obese HF patients across the LVEF spectrum
Using a lower dose of medication will slow weight loss, but it may cause fewer cosmetic side effects
That's compared to a 2% loss for those using metformin after two years
An endocrinologist explains the off-label practice of microdosing weight-loss drugs, how it works, and the potential health risks
